Cardiovascular Disease Prevention Clinical Quality Measures by Ownership Type*
| Measure | Observations† | Physician-Owned Practices | Health System/Medical Group Practices | FQHC Practices | ||||
|---|---|---|---|---|---|---|---|---|
| Value | Value | Difference (95% CI) | P value | Value | Difference (95% CI) | P value | ||
| Aspirin (Values showing %) | 886 | 57.5 | 67.5 | 10.0 (0.2 to 21.5) | .08 | 59.1 | 1.6 (−8.2 to 10.5) | .73 |
| Blood pressure (Values showing %) | 892 | 64.0 | 60.6 | 3.4 (−7.3 to 2.0) | .15 | 64.3 | 0.3 (−6.4 to 9.2) | .94 |
| Cholesterol (Values showing %) | 679 | 58.2 | 58.2 | 0.1 (−8.7 to 14.3) | .99 | 55.2 | 3.0 (−7.9 to 4.7) | .38 |
| Smoking (Values showing %) | 869 | 51.0 | 67.3 | 16.3 (1.8 to 24.2) | .004 | 69.3 | 18.3 (1.1 to 26.7) | .004 |
| Number of practices (Values showing numbers) | 989 | 526 | 253 | 210 | ||||
↵* Based on practice surveys of practices participating in EvidenceNOW, collected between October 2015 and April 2017. See Appendix A for a definition of the four cardiovascular disease prevention clinical quality measures.
↵† The column “Observations” shows the number of practices with an observed value for the respective measure.
CI, confidential interval; FQHC, federally qualified health center.